SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-021982
Filing Date
2021-02-12
Accepted
2021-02-12 16:30:43
Documents
1
Group Members
G. YAROM MEDICAL RESEARCH LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A tm215735d1_sc13ga.htm SC 13G/A 79681
  Complete submission text file 0001104659-21-021982.txt   81021
Mailing Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317
Business Address 16 ZE'EV TYOMKIN ST. (4TH FL.) TEL AVIV L3 6578317 97236938448
Galmed Pharmaceuticals Ltd. (Subject) CIK: 0001595353 (see all company filings)

IRS No.: 981147233 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88495 | Film No.: 21628156
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GALMED PHARMACEUTICALS,8 SHAUL HAMELECH BLVD., AMOT HAMISHPAT BLDG. TEL AVIV L3 64733
Business Address
Baharaff Allen (Filed by) CIK: 0001630334 (see all company filings)

Type: SC 13G/A